av/teklalife-sciences-investors--big.svg

NYSE:HQL

Tekla Life Sciences Investors

  • Stock

USD

Last Close

16.06

06/11 21:10

Market Cap

397.95M

Beta: 0.83

Volume Today

105.41K

Avg: 77.50K

Dividend Yield

9.13%

Payout:62.47%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '15
Sep '16
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
Sep '24
asset turnover
0.00
-
0.00
21.73%
0.15
4,231.58%
0.06
58.19%
-0.18
387.50%
0.26
243.03%
0.12
52.02%
-0.25
302.46%
0.06
123.47%
0.19
222.11%
cash conversion cycle
77.62
-
2.33K
2,906.95%
-103.67
104.44%
-42.70
58.81%
1.49K
-
cash per share
0.00
-
0.00
2,289.21%
0.03
5,834.82%
0.00
99.99%
0.05
2,961,603.48%
0.00
-
0.00
52.96%
0.57
2,963,469.83%
company equity multiplier
1.01
-
1.01
0.44%
1.00
0.21%
1.01
0.20%
1.01
0.24%
1.00
0.74%
1.02
1.93%
1.04
2.13%
1.00
3.90%
1.00
0.03%
days of inventory outstanding
1.41K
-
days of payables outstanding
271.97
-
168.84
37.92%
103.77
38.54%
179.68
73.16%
days of sales outstanding
349.59
-
2.50K
615.90%
0.09
100.00%
136.99
144,422.04%
-20.90
115.26%
0.22
101.04%
0.80
267.26%
-2.20
376.08%
78.27
3,651.40%
0.97
98.76%
dividend yield
ebit per revenue
-3.57
-
-2.64
26.13%
-0.06
97.89%
-0.12
117.70%
1.02
940.29%
0.99
2.43%
0.98
0.94%
1.01
3.13%
0.95
6.21%
ebt per ebit
-8.58
-
3.14
136.64%
-17.67
662.46%
-7.95
55.04%
1
112.58%
1
0%
1
0%
1
0%
1
0%
effective tax rate
0.00
-
0.00
20.28%
enterprise value multiple
5.17
-
-19.39
475.16%
3.25
116.75%
7.78
139.51%
-4.72
160.62%
3.41
172.22%
7.82
129.52%
-3.03
138.71%
14.95
593.76%
fixed asset turnover
free cash flow per share
gross profit margin
-3.27
-
-2.17
33.79%
0.93
143.14%
0.84
10.06%
1
19.05%
1
0%
1
0%
1
0%
0.78
22.29%
1
28.69%
interest coverage
-0.10
-
0.47
547.00%
-0.05
111.47%
-0.11
108.73%
inventory turnover
0.26
-
long term debt to capitalization
net income per ebt
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
net profit margin
30.62
-
-8.29
127.07%
0.98
111.85%
0.96
2.12%
1.02
5.74%
0.99
2.43%
0.98
0.94%
1.01
3.13%
0.95
6.21%
0.98
3.55%
operating cash flow per share
operating cycle
349.59
-
2.50K
615.90%
0.09
100.00%
136.99
144,422.04%
1.49K
-
operating profit margin
-3.57
-
-2.64
26.13%
-0.06
97.89%
-0.12
117.70%
1.02
940.29%
0.99
2.43%
0.98
0.94%
1.01
3.13%
0.95
6.21%
payables turnover
1.34
-
2.16
61.08%
3.52
62.71%
2.03
42.25%
pretax profit margin
30.62
-
-8.29
127.07%
0.98
111.85%
0.96
2.12%
1.02
5.74%
0.99
2.43%
0.98
0.94%
1.01
3.13%
0.95
6.21%
0.98
3.55%
price fair value
0.96
-
0.94
2.21%
0.98
5.07%
1.00
1.39%
0.87
12.81%
0.87
0.30%
0.96
11.19%
0.80
17.45%
0.83
4.45%
receivables turnover
1.04
-
0.15
86.03%
3.85K
2,640,292.71%
2.66
99.93%
-17.46
755.37%
1.68K
9,715.68%
457.21
72.77%
-165.61
136.22%
4.66
102.82%
375.09
7,943.74%
return on assets
0.09
-
-0.03
132.95%
0.15
613.23%
0.06
59.07%
-0.18
404.01%
0.25
239.55%
0.12
52.47%
-0.25
308.79%
0.06
122.01%
0.19
233.56%
return on capital employed
-0.01
-
-0.01
10.43%
-0.01
8.96%
-0.01
8.78%
-0.18
2,321.62%
0.25
238.53%
0.12
52.47%
-0.26
311.39%
0.06
121.74%
return on equity
0.09
-
-0.03
132.80%
0.15
612.13%
0.06
58.99%
-0.18
404.74%
0.25
238.52%
0.12
51.55%
-0.26
313.24%
0.06
121.15%
0.19
233.65%
total debt to capitalization

All numbers in USD (except ratios and percentages)